ReShape Lifesciences
RSLS3.9200.00% ( 0.000 )
Q1 FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.03.31
Overview: ReShape Lifesciences(RSLS) the Revenue is 1.113 M (-42.75%);the EBIT is -1.839 M (+16.79%);the EPS is 18.98 (+114%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B42.75%
----
----
EBIT
-0.00B16.79%
----
----
EPS
18.9782114.02%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf